NYSE:MRT - MedEquities Realty Trust Stock Price, News, & Analysis Sign in or create an account to add this stock to your watchlist. Get Started $9.99 +0.33 (+3.42 %) (As of 09/23/2018 04:00 PM ET)Previous Close$9.99Today's Range$9.64 - $10.0252-Week Range$9.46 - $12.05Volume733,655 shsAverage Volume176,222 shsMarket Capitalization$318.31 millionP/E Ratio8.32Dividend Yield8.41%Beta-0.16 Company ProfileDiscussionAnalyst RatingsChartDividend HistoryEarnings HistoryFinancialsInsider TradesHeadlinesOptions ChainSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email MedEquities Realty Trust (NYSE: MRT) is a self-managed and self-administered real estate investment trust that invests in a diversified mix of healthcare properties and healthcare-related real estate debt investments. The Company's management team has extensive industry experience in acquiring, owning, developing, financing, operating, leasing and monetizing many types of healthcare properties and portfolios. MedEquities' strategy is to become an integral capital partner with high-quality and growth-oriented facility-based providers of healthcare services on a nationwide basis, primarily through net-leased real estate investment. Receive MRT News and Ratings via Email Sign-up to receive the latest news and ratings for MRT and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange NYSE Industry Real estate investment trusts Sub-IndustryN/A SectorFinance SymbolNYSE:MRT CUSIPN/A Webwww.medequities.com Phone615-627-4710 Debt Debt-to-Equity RatioN/A Current Ratio9.27 Quick Ratio9.27 Price-To-Earnings Trailing P/E Ratio8.32 Forward P/E Ratio9.25 P/E GrowthN/A Sales & Book Value Annual Sales$61.10 million Price / Sales5.21 Cash Flow$1.1978 per share Price / Cash8.34 Book Value$11.23 per share Price / Book0.89 Profitability EPS (Most Recent Fiscal Year)$1.14 Net Income$20.42 million Net Margins30.84% Return on Equity5.73% Return on Assets3.44% Miscellaneous Employees12 Outstanding Shares31,860,000Market Cap$318.31 million MedEquities Realty Trust (NYSE:MRT) Frequently Asked Questions What is MedEquities Realty Trust's stock symbol? MedEquities Realty Trust trades on the New York Stock Exchange (NYSE) under the ticker symbol "MRT." How often does MedEquities Realty Trust pay dividends? What is the dividend yield for MedEquities Realty Trust? MedEquities Realty Trust announced a quarterly dividend on Thursday, August 2nd. Investors of record on Wednesday, August 15th will be given a dividend of $0.21 per share on Wednesday, August 29th. This represents a $0.84 dividend on an annualized basis and a yield of 8.41%. The ex-dividend date is Tuesday, August 14th. View MedEquities Realty Trust's Dividend History. How were MedEquities Realty Trust's earnings last quarter? MedEquities Realty Trust Inc (NYSE:MRT) released its earnings results on Wednesday, August, 8th. The financial services provider reported $0.10 earnings per share for the quarter, missing analysts' consensus estimates of $0.30 by $0.20. The financial services provider earned $17.56 million during the quarter, compared to analysts' expectations of $17.03 million. MedEquities Realty Trust had a net margin of 30.84% and a return on equity of 5.73%. View MedEquities Realty Trust's Earnings History. When is MedEquities Realty Trust's next earnings date? MedEquities Realty Trust is scheduled to release their next quarterly earnings announcement on Tuesday, November, 6th 2018. View Earnings Estimates for MedEquities Realty Trust. What price target have analysts set for MRT? 8 brokers have issued 1-year price targets for MedEquities Realty Trust's stock. Their forecasts range from $9.00 to $14.00. On average, they anticipate MedEquities Realty Trust's share price to reach $11.8750 in the next twelve months. This suggests a possible upside of 18.9% from the stock's current price. View Analyst Price Targets for MedEquities Realty Trust. What is the consensus analysts' recommendation for MedEquities Realty Trust? 8 Wall Street analysts have issued "buy," "hold," and "sell" ratings for MedEquities Realty Trust in the last year. There are currently 1 sell rating, 3 hold ratings and 4 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for MedEquities Realty Trust. What are Wall Street analysts saying about MedEquities Realty Trust stock? Here are some recent quotes from research analysts about MedEquities Realty Trust stock: 1. According to Zacks Investment Research, "MedEquities Realty Trust, Inc. owns, develops, operates, leases and disposes healthcare properties and portfolios. It operates primarily in Texas, California, Nevada and South Carolina. MedEquities Realty Trust, Inc. is based in Nashville, Tennessee. " (9/15/2018) 2. Cantor Fitzgerald analysts commented, "MRT reported in-line 4Q17 results and issued 2018 guidance that includes fewer acquisitions than we modeled, and we believe could be conservative. Closings have been slower industry-wide, but the backlog of announced deals is good for 2018." (2/21/2018) Who are some of MedEquities Realty Trust's key competitors? Some companies that are related to MedEquities Realty Trust include PennyMac Mortgage Investment Trust (PMT), Saul Centers (BFS), CorePoint Lodging (CPLG), Easterly Government Properties (DEA), TIER REIT (TIER), Hannon Armstrong Sustnbl Infrstr Cap (HASI), CYS INVESTMENTS/SH SH (CYS), KKR Real Estate Finance Trust (KREF), Ramco-Gershenson Properties Trust (RPT), CYRELA BRAZIL R/S (CYRBY), Universal Health Realty Income Trust (UHT), ARMOUR Residential REIT (ARR), Chatham Lodging Trust (CLDT), Interrent Real Estate Investment Trust (IIPZF) and InfraREIT (HIFR). Who are MedEquities Realty Trust's key executives? MedEquities Realty Trust's management team includes the folowing people: Mr. John W. McRoberts, Chairman & CEO (Age 65)Mr. William C. Harlan, Pres, COO & Director (Age 66)Mr. Jeffery C. Walraven, Exec. VP, CFO, Sec. & Treasurer (Age 48)Mr. David Louis Travis, Sr. VP & Chief Accounting Officer (Age 43)Mr. Tripp Sullivan, Investor Relations, SCR Partners, LLC When did MedEquities Realty Trust IPO? (MRT) raised $259 million in an initial public offering on Thursday, September 29th 2016. The company issued 19,900,000 shares at a price of $12.00-$14.00 per share. FBR, J.P. Morgan, Citigroup, KeyBanc Capital Markets, Raymond James and RBC Capital Markets served as the underwriters for the IPO and JMP Securities, Fifth Third Securities and Capital One Securities were co-managers. Who are MedEquities Realty Trust's major shareholders? MedEquities Realty Trust's stock is owned by many different of institutional and retail investors. Top institutional shareholders include BlueMountain Capital Management LLC (6.89%), American Century Companies Inc. (6.81%), BlackRock Inc. (4.70%), Aristotle Capital Boston LLC (2.88%), Renaissance Technologies LLC (2.64%) and Eagle Boston Investment Management Inc. (2.45%). Company insiders that own MedEquities Realty Trust stock include Bluemountain Capital Managemen, David L Travis, Jeffery C Walraven, John W Mcroberts, Randy L Churchey and William C Harlan. View Institutional Ownership Trends for MedEquities Realty Trust. Which institutional investors are selling MedEquities Realty Trust stock? MRT stock was sold by a variety of institutional investors in the last quarter, including Boston Partners, BlueMountain Capital Management LLC, Aristotle Capital Boston LLC, GSA Capital Partners LLP, Moody Lynn & Lieberson LLC, Victory Capital Management Inc. and Raymond James & Associates. View Insider Buying and Selling for MedEquities Realty Trust. Which institutional investors are buying MedEquities Realty Trust stock? MRT stock was acquired by a variety of institutional investors in the last quarter, including Renaissance Technologies LLC, Sterling Capital Management LLC, BlackRock Inc., American Century Companies Inc., Eagle Boston Investment Management Inc., Sei Investments Co., Putnam Investments LLC and Dynamic Technology Lab Private Ltd. Company insiders that have bought MedEquities Realty Trust stock in the last two years include David L Travis, Jeffery C Walraven, John W Mcroberts, Randy L Churchey and William C Harlan. View Insider Buying and Selling for MedEquities Realty Trust. How do I buy shares of MedEquities Realty Trust? Shares of MRT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab. What is MedEquities Realty Trust's stock price today? One share of MRT stock can currently be purchased for approximately $9.99. How big of a company is MedEquities Realty Trust? MedEquities Realty Trust has a market capitalization of $318.31 million and generates $61.10 million in revenue each year. The financial services provider earns $20.42 million in net income (profit) each year or $1.14 on an earnings per share basis. MedEquities Realty Trust employs 12 workers across the globe. What is MedEquities Realty Trust's official website? The official website for MedEquities Realty Trust is http://www.medequities.com. How can I contact MedEquities Realty Trust? MedEquities Realty Trust's mailing address is 3100 WEST END AVENUE SUITE 1000, NASHVILLE TN, 37203. The financial services provider can be reached via phone at 615-627-4710 or via email at [email protected] MarketBeat Community Rating for MedEquities Realty Trust (NYSE MRT)Community Ranking: 2.3 out of 5 ( )Outperform Votes: 159 (Vote Outperform)Underperform Votes: 186 (Vote Underperform)Total Votes: 345MarketBeat's community ratings are surveys of what our community members think about MedEquities Realty Trust and other stocks. Vote "Outperform" if you believe MRT will outperform the S&P 500 over the long term. Vote "Underperform" if you believe MRT will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 9/23/2018 by MarketBeat.com StaffFeatured Article: How Do Tariffs Affect Trade Balances?